Assessment of the efficacy and safety of 5-FU/CDDP/Cetuximab (FPE) induction chemotherapy in patients with locally advanced head and neck squamous cell carcinoma
Phase 2
Completed
- Conditions
- locally advanced head and neck squamous cell carcinoma
- Registration Number
- JPRN-UMIN000031146
- Lead Sponsor
- Saga University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 25
Inclusion Criteria
Not provided
Exclusion Criteria
Performance status 2 and more
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method response rate of consecutive 3 courses
- Secondary Outcome Measures
Name Time Method safety(CTCAE), progression free survival, compliance(dose intensity)